Key result
Complete surgical resection fails to prevent 6-month recurrence of aggressive primary cardiac myxofibrosarcoma.
Why the study?
Primary cardiac myxofibrosarcoma is a rare, aggressive malignancy with limited treatment options and high recurrence rates, presenting diagnostic and therapeutic challenges.
Case Report (n=1)
This case highlights the diagnostic challenges and high recurrence rate of primary cardiac myxofibrosarcoma despite complete surgical resection, emphasizing the role of multimodal imaging and potential need for adjuvant therapies.
Recurrence risk in resected cardiac myxofibrosarcoma warrants close surveillance; leaves open optimal adjuvant strategies in larger cohorts.
Introduction: Primary cardiac myxofibrosarcoma (MFS) is a rare and aggressive malignancy, with limited treatment options and a high recurrence rate. Multimodal imaging is critical for diagnosis, and surgery remains the primary treatment, though recurrence is common. Case Presentation: We present the case of a 41-year-old male with history of intermittent chest pain and palpitations. Initial work-up revealed a left atrial mass, which after thorough evaluation with multimodal imaging and histopathological assessment, was diagnosed as a primary cardiac myxofibrosarcoma. Despite complete surgical resection and low-grade histology, recurrence ensued, prompting reintervention and adjuvant radiotherapy. Discussion: Cardiac MFS poses significant diagnostic challenges. Multimodal imaging and immunohistochemistry are key to diagnosis. While surgery is the mainstay of treatment, high recurrence rates necessitate consideration of adjuvant therapies and long-term monitoring. Conclusion: This case highlights the importance of differential diagnosis of intracardiac masses, as well as reaching a consensus regarding the approach for malignant cardiac tumors.
No takes yet. Share an insight, caveat, or question.
Santa-Ana-Bayona et al. (2024) conducted a case report in Primary Cardiac Myxofibrosarcoma (n=1). Surgical resection was evaluated on Tumor recurrence. A 41-year-old male with primary cardiac myxofibrosarcoma experienced tumor recurrence six months after complete surgical resection, highlighting the aggressive nature of this rare malignancy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: